Quantitative Human Anti-Glycoprotein 210 Antibody Competitive ELISA Kit

The quantitative human anti-glycoprotein 210 antibody competitive ELISA kit is designed to detect the level of human anti-glycoprotein 210 antibody (GP210-Ab). Employing the principles of enzyme-linked immunosorbent assay, the kit leverages the specific antigen-antibody interaction, followed by an enzyme-catalyzed colorimetric reaction. The resulting absorbance is then measured to determine the antibody concentration. Compatible with a wide range of biological samples, including tissue homogenates, cell culture supernatants, serum, or plasma, this kit offers high sensitivity and specificity, enabling the precise detection of even low concentrations of anti-glycoprotein 210 antibodies.

GP210-Ab

Tissue homogenates, cell culture supernatants, serum, plasma

50 μL-100 μL

5 ng/mL

Quantitative competitive ELISA

50 ng/mL-500 ng/mL

1 h-5 h

450 nm

Store at 2-8°C for long term storage.

Human

Anti-glycoprotein 210 antibody

Anti-gp210 antibody; Antibody to glycoprotein 210; Gp210 antibody; Anti-gp210; Glycoprotein 210 antibody; Anti-nuclear pore glycoprotein 210 antibody; Anti-nup210 antibody; GP210-Ab

Anti-Glycoprotein 210 antibodies are important autoantibody markers for primary biliary cholangitis (PBC), which are of great significance for the early diagnosis and monitoring of the disease. Through the competitive ELISA method, this kit can detect GP-Ab210 antibodies with high sensitivity and specificity, which plays an important role in the scientific research and drug development of autoimmune liver diseases.

Pre-coated 96-well ELISA plate; Standard solution; Enzyme conjugate; Various diluents; Wash buffer; Substrate solution; Stop solution

Intra-Assay: n=20, CV <8%;
Inter-Assay: n=20, CV <10%;

90-105%